编号 | 时间 | 类型 | 题目 | 讲者 | 单位 |
---|---|---|---|---|---|
1 | 08:30-08:50 | 专题发言 |
Durability and cross-reactive immune memory to SARS-CoV-2 in individuals recovered from COVID-19 |
王健伟 | 中国医学科学院北京协和医学院 |
2 | 08:50-09:10 | 专题发言 |
Immune regulation and deep tissue profiling in transplantation and beyond |
Fadi Issa | University of Oxford |
3 | 09:10-09:30 | 专题发言 |
Understanding maladaptive responses to severe infection |
Ping Zhang | University of Oxford, Wellcome Centre for Human Genetics |
4 | 09:10-09:30 | 专题发言 |
Understanding maladaptive responses to severe infection |
Julian Knight | University of Oxford |
5 | 09:30-09:50 | 专题发言 |
Cytotoxic T cell in emerging virus infection / Characterizing SARS-CoV-2 specific T cells |
Tao Dong | Oxford University |
6 | 09:30-09:50 | 专题发言 |
Cytotoxic T cell in emerging virus infection / Characterizing SARS-CoV-2 specific T cells |
Yanchun Peng | University of Oxford, COI |
7 | 09:50-10:00 | 专题发言 |
Visualising the ultrastructural interplay between SARS-CoV-2 and the cellular hypoxic response |
Peter Wing | Chinese Academy of Medical Sciences, Oxford Institute. Nuffield Department of Medicine |
8 | 10:00-10:10 | 专题发言 |
Using single-particle cryoEM to study the structure of TCR-pMHC complexes responding to SARS-CoV-2 infection |
Nathan Hardenbrook | University of Oxford |
编号 | 时间 | 类型 | 题目 | 讲者 | 单位 |
---|---|---|---|---|---|
1 | 11:00-11:20 | 专题发言 |
COVID vaccine development and testing- lessons learnt |
Teresa Lambe | The University of Oxford - Oxford Vaccine Group- Pandemic Sciences Institute |
2 | 11:20-11:40 | 专题发言 |
The ChAdOx1 vaccine plalorm technology, COVID19, MERS, Nipah and Lassa vaccine development |
Sarah Gilbert | Pandemic Sciences Institute, University of Oxford |
3 | 11:40-12:00 | 专题发言 |
Neutralising antibodies and vaccination drive the evolution of SARS-CoV-2 |
Chang Liu | Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK |
4 | 12:00-12:10 | 专题发言 |
Antibodies, vaccine, and drug therapeutics targeting influenza neuraminidase |
Pramila Rijal | University of Oxford |
5 | 12:10-12:40 | 讨论点评 |
Flash Talks |